Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Non-Current Deferred Tax Liability (2021 - 2023)

Prokidney's (PROK) quarterly Non-Current Deferred Tax Liability came in at $1.5 million in Q4 2023, down 13.29% year-over-year from $1.7 million in Q4 2022, and down 13.29% quarter-over-quarter from $1.7 million in Q4 2022.

Analysis

Prokidney (PROK) Non-Current Deferred Tax Liability (2021 - 2023) Analysis & Trends

Prokidney (PROK) has reported Non-Current Deferred Tax Liability for 3 consecutive years, with $1.5 million the latest figure, recorded in Q4 2023.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 13.29% year-over-year to $1.5 million in Q4 2023; TTM through Dec 2023 was $1.5 million, a 13.29% decrease from a year earlier, with the FY2023 full-year figure at $1.5 million, down 13.29% from the prior year.
  • Non-Current Deferred Tax Liability was $1.5 million for Q4 2023 at Prokidney, down from $1.7 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $1.7 million in Q4 2022 and troughed at $47000.0 in Q4 2021.
  • A 3-year average of $1.1 million and a median of $1.5 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 3534.04% in 2022 and retreated 13.29% in 2023, its largest moves.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $47000.0 in 2021, then surged by 3534.04% to $1.7 million in 2022, then fell by 13.29% to $1.5 million in 2023.
  • The last three Non-Current Deferred Tax Liability figures came in at $1.5 million (Q4 2023), $1.7 million (Q4 2022), and $47000.0 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.48 Mn
Dec 31, 2022 1.71 Mn
Dec 31, 2021 47,000.00